Differential prognostic impact of the mutational status of B-RAF and N-RAS in melanoma

被引：0
|
作者：
Ugurel, S
Thirumaran, RK
Blöthner, S
Gast, A
Sucker, A
Müller-Berhaus, J
Rittgen, W
Hemminki, K
Kumar, R
Schadendorf, D
机构：
[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
[2] Univ Med Ctr Mannheim, Dept Dermatol, Skin Canc Unit, Mannheim, Germany
[3] German Canc Res Ctr, Cent Unit Biostat, D-6900 Heidelberg, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2006年 / 15卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [1] Detection of B-RAF and N-RAS mutations in human melanoma
    Goydos, JS
    Mann, B
    Kim, HJ
    Gabriel, EM
    Alsina, J
    Germino, FJ
    Shih, W
    Gorski, DH
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 200 (03) : 362 - 370
  • [2] Pulverizing Metastatic Melanoma Beyond the B-RAF and N-RAS Chunks
    Moschos, Stergios
    ONCOLOGIST, 2012, 17 : 6 - 6
  • [3] C-kit, B-raf, and N-ras mutations in melanoma subtypes
    Pracht, Marc
    Mogha, Ariane
    Fautrel, Alain
    Lespagnol, Alexandra
    Mouchet, Nicolas
    Le Gall, Francois
    Oger, Emmanuel
    Galibert, Marie-Dominique
    Lesimple, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma
    van Dijk, MCRF
    Bernsen, MR
    Ruiter, DJ
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1145 - 1151
  • [5] Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
    Bloethner, S
    Chen, BW
    Hemminki, K
    Müller-Berghaus, J
    Ugurel, S
    Schadendorf, D
    Kumar, R
    CARCINOGENESIS, 2005, 26 (07) : 1224 - 1232
  • [6] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UAI-201
    Lee, Michael
    Ahn, Jun-Ho
    Ahn, Soon Kil
    FASEB JOURNAL, 2012, 26
  • [7] Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152
    Kim, Yun-Ki
    Ahn, Soon Kil
    Lee, Michael
    CANCER LETTERS, 2012, 320 (02) : 215 - 224
  • [8] B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis
    Ugurel, Selma
    Thirumaran, Ranjit K.
    Bloethner, Sandra
    Gast, Andreas
    Sucker, Antje
    Mueller-Berghaus, Jan
    Rittgen, Werner
    Hemminki, Kari
    Becker, Juergen C.
    Kumar, Rajiv
    Schadendorf, Dirk
    PLOS ONE, 2007, 2 (02):
  • [9] Active N-Ras and B-Raf Inhibit Anoikis by Downregulating Bim Expression in Melanocytic Cells
    Goldstein, Nathaniel B.
    Johannes, Widya U.
    Gadeliya, Agnessa V.
    Green, Matthew R.
    Fujita, Mayumi
    Norris, David A.
    Shellman, Yiqun G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (02) : 432 - 437
  • [10] The tyrosine kinase receptor, EphA2, is overexpressed, but not associated with N-Ras or B-RAF mutation in metastatic melanoma lesions
    Kim, Kevin B.
    Kim, Jihyun
    Diwan, Abdul H.
    Prieto, Victor G.
    Johnson, Marilyn K.
    Hwang, Cindy S.
    Wei, Caimiao
    Detry, Michelle A.
    Sood, Anil K.
    Ellerhorst, Julie A.
    ANNALS OF ONCOLOGY, 2006, 17 : 165 - 165
12345